2023 ASCO GU Prostate and RCC Highlights With Daniel George, MD

By The Uromigos - Last Updated: August 1, 2023

The Uromigos are joined by Daniel George, MD, to review presentations from the 2023 ASCO GU Cancers Symposium, including triplet versus doublet therapy, the ARASENS trial, and the ZIRCON phase 3 trial.
Dr. George is a medical oncologist at Duke Health, specializing in genitourinary malignancies.

Post Tags:Uromigos-ASCO GUUromigos-Kidney CancerUromigos-Prostate Cancer